FDA Warns 13 Web Firms re Unlawful Drug Sales

The CDER Office of Drug Security, Integrity, and Response has sent Warning Letters to 13 Internet-based companies operating scores of individual Web sites that the agency says are offering unapproved new drugs and misbranded drugs for sale in U.S. commerce. The 13 companies are 247Med, Pharm Cash, Glay Med, Worldwide Drug Store, Medicina Mexico, Rx Partners, Bulk2USA, Can America Global, American Pharmacy Group, MediPK, Pharmempire, HA Stores Ltd., and My Rx Cash.

The letters give examples of the unapproved and misbranded drugs each site is offering and say that the agency is taking action “because of the inherent risk to consumers who purchase unapproved new drugs and misbranded drugs.” The companies were told to respond with a list of steps taken or planned to correct the violations and prevent their recurrence, with a timetable for completion.